WELLS FARGO & COMPANY/MN - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 53 filers reported holding SPERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$623
-18.8%
515
-2.6%
0.00%
Q2 2023$767
+3.5%
529
+3.5%
0.00%
Q1 2023$741
+5.0%
511
+25.2%
0.00%
Q4 2022$706408
+1.2%
0.00%
Q3 2022$0
-100.0%
403
-54.8%
0.00%
Q2 2022$1,000
-99.2%
891
-93.8%
0.00%
Q1 2022$124,000
-65.8%
14,283
-37.1%
0.00%
Q4 2021$363,000
+152.1%
22,694
+192.2%
0.00%
Q3 2021$144,000
-74.1%
7,766
-80.5%
0.00%
Q2 2021$556,000
+109.8%
39,847
+122.4%
0.00%
Q1 2021$265,000
-67.3%
17,920
-57.1%
0.00%
Q4 2020$811,000
+117.4%
41,799
+25.2%
0.00%
Q3 2020$373,000
-25.8%
33,375
-10.2%
0.00%
Q2 2020$503,000
+131.8%
37,186
+38.8%
0.00%
Q1 2020$217,000
+14.8%
26,796
+36.5%
0.00%
Q4 2019$189,000
+3.3%
19,625
+13.6%
0.00%
Q3 2019$183,000
+16.6%
17,274
+26.5%
0.00%
Q2 2019$157,000
+157.4%
13,660
+187.9%
0.00%
Q1 2019$61,000
-30.7%
4,745
-66.7%
0.00%
Q4 2018$88,000
+252.0%
14,240
+510.1%
0.00%
Q3 2018$25,000
+108.3%
2,334
+185.7%
0.00%
Q2 2018$12,000
-20.0%
817
-22.4%
0.00%
Q1 2018$15,000
+36.4%
1,053
+6.4%
0.00%
Q4 2017$11,0009900.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders